Search
for
Sort by
Research 30 of 1000+
- Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil
- Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil
- Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- A hospital-based study to assess the prevalence of Androgenetic alopecia in young male patients admitted to a Cardiac care unit (2021)
- Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield
- Emergency preparedness in hair restoration surgery
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Primary cardiac angiosarcoma mimicking minoxidil-related pericarditis: a case report
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Anabolic androgenic steroids impact on cardiovascular risk and cardiovascular events. The literature review
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- SAT-279 The Effect of Chronic 5-alpha Reductase Inhibition on Clinically Apparent and Silent Cardiovascular Events
- Cardiodermatology in the physician’s practice
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Inflammation as a Modifiable Driver of Ischemic Heart Disease: Mechanisms, Clinical Risks, and Evolving Therapeutic Options
- ZAOSTRZENIA NIEWYDOLNOŚCI ODDECHOWEJ- PRZYCZYNY I POSTĘPOWANIE
- Heart failure associated with minoxidil intoxication in a cat
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscle
- Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- Side effects of low-dose oral minoxidil for treating alopecia
- Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer
- A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer